Related Experiment Video

Updated: May 13, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase

Vivian W L Yu1, Wing Shing Ho

  • 1School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, SAR, PR China.

Oncology Reports
|March 26, 2013
PubMed

Insights

Tetrandrine, derived from Stephania tetrandra, inhibits liver cancer cell growth by halting cell cycle progression. Its anti-cancer effects in hepatocellular carcinoma (HCC) appear to involve p53-independent pathways.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Phytochemicals, such as tetrandrine from Stephania tetrandra, show promise in cancer therapy.
  • Understanding tetrandrine's mechanism in liver cancer is crucial for therapeutic development.
  • p53-independent pathways are vital in phytochemical-induced apoptosis and cancer metastasis.

Purpose of the Study:

  • To investigate the anti-cancer effects and mechanisms of tetrandrine in hepatocellular carcinoma (HCC) cells.
  • To determine if tetrandrine-induced apoptosis in HCC cells is mediated by p53-independent pathways.

Main Methods:

  • Treatment of Huh-7 hepatocellular carcinoma cells with tetrandrine.
  • Cell cycle progression analysis.
  • Western blot analysis for apoptosis-related proteins (Bax, Bcl, p53, survivin, PCNA, PARP, p21, caspase-3).
  • DNA fragmentation assays.

Main Results:

  • Tetrandrine significantly inhibited HCC cell proliferation.
  • Cell cycle arrest was observed at the G2/M phase.
  • Expression levels of Bax, Bcl, p53, survivin, PCNA, PARP, and p21 were altered.
  • Tetrandrine increased caspase-3 expression and induced DNA fragmentation.
  • These effects suggest a p53-independent mechanism.

Conclusions:

  • Tetrandrine exhibits anti-cancer properties against hepatocellular carcinoma cells.
  • The anti-cancer effects are mediated through the inhibition of cell cycle progression and induction of apoptosis.
  • The mechanism of action appears to involve p53-independent pathways.

More Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...